Evidence map›Paper›PMID 41654506›Full record

ArticleNature communications2026

Discovery of antimicrobial peptides targeting Acinetobacter baumannii via a pre-trained and fine-tuned few-shot learning-based pipeline.

Junjie Huang, Wentao Zhang, Aowen Wang, Yunzhi Jiang, Yuxian Lai, Yanchao Xu, Cong Wang, Junbo Zhao, Peng Zhang, Jian Ji

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Junjie Huang *MOE Key Laboratory of Macromolecule Synthesis and Functionalization of Ministry of Education, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, PR China.
Wentao Zhang *College of Computer Science and Technology, Zhejiang University, Hangzhou, PR China.
Aowen Wang *College of Computer Science and Technology, Zhejiang University, Hangzhou, PR China.
Yunzhi JiangCenter for AI and Intelligent Medicine, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, PR China.
Yuxian LaiMOE Key Laboratory of Macromolecule Synthesis and Functionalization of Ministry of Education, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, PR China.
Yanchao XuCollege of Computer Science and Technology, Zhejiang University, Hangzhou, PR China.
Cong WangMOE Key Laboratory of Macromolecule Synthesis and Functionalization of Ministry of Education, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, PR China.
Junbo ZhaoCollege of Computer Science and Technology, Zhejiang University, Hangzhou, PR China. j.zhao@zju.edu.cn.ORCID 0000-0002-3637-2936
Peng ZhangMOE Key Laboratory of Macromolecule Synthesis and Functionalization of Ministry of Education, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, PR China. zhangp7@zju.edu.cn.ORCID 0000-0002-5409-7480
Jian JiMOE Key Laboratory of Macromolecule Synthesis and Functionalization of Ministry of Education, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, PR China. jijian@zju.edu.cn.ORCID 0000-0001-9870-4038

Funding

National Natural Science Foundation of China (National Science Foundation of China) 32401159National Natural Science Foundation of China (National Science Foundation of China) 52293381Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation) LR25E030001Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation) QKHM25B0502
6 · The paper itself

Abstract

Acinetobacter baumannii, a robust Gram-negative bacterium known for causing nosocomial infections, exhibiting multidrug resistance, and lacking antimicrobial peptides that target it, remains hard to treat. Here, we report a few-shot learning pipeline integrating classification, ranking, and regression modules. Each module is trained via a few-shot learning strategy involving pre-training and multiple fine-tuning steps, incorporating similar and true data for fine-tuning, to identify potent AMPs against Acinetobacter baumannii. This pipeline effectively scans complete libraries of hexapeptides, heptapeptides, and octapeptides (encompassing tens of billions of candidates) despite the extreme scarcity of training data. Results show it discovers AMPs active against Acinetobacter baumannii and Candida albicans, with low off-target toxicity and negligible drug resistance susceptibility. Additionally, EME7(7) controls Acinetobacter baumannii pneumonia in mice without kidney injury, a contrast to the observed effects of polymyxin B. This work provides a paradigm for addressing challenges of limited data availability.

Indexed as

Acinetobacter baumanniiAnti-Bacterial AgentsAntimicrobial PeptidesDrug DiscoveryAcinetobacter InfectionsAnimalsCandida albicansMiceMicrobial Sensitivity TestsAnti-Bacterial AgentsAntimicrobial Peptides

Identifiers

PMID41654506
PMCPMC12992665

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.